Historical:
Biopure Corporation developed two hemoglobin-based blood substitutes—Hemopure for humans and Oxyglobin for veterinary use. Hemopure was approved in South Africa and Russia but failed to gain FDA approval due to safety concerns. The company went bankrupt in 2009.
Current:
BioPure, now a WMFTS brand, specializes in high-purity single-use fluid path components supporting cGMP-compliant manufacturing across global biotech/pharma industries.
Therapeutic areas
OtherHematology
Modalities
Hemoglobin-based oxygen carriers (HBOCs) as blood substitutesSingle-use fluid path components and connectors for bioprocessing; not directly therapeutic but enabling technology for biologics manufacturing
Industry
Chemicals & Materials
02
Drug pipeline
2 assets
hemopure
Commercial
Indications
Anemia, Blood loss
1 more asset in the full pipeline.
03
Partnerships
U.S. Navy collaboration on trauma applications with Hemopurevarious regulatory partnerships during clinical development phase.No major disclosed pharma partnerships—focuses on supplying manufacturers globally with single-use process solutions rather than direct R&D collaborations.
Beyond the preview
Go deeper on Biopure.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
Trial phase
Status
Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
Partners
Deal terms
Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
Funding rounds
Investors
Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
Peer companies
Targets
Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
Platforms
Patents
Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
Company news
Sources
Analysis
Bring the full picture into focus.
See how Gosset can support your research on Biopure.